Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Melanie Ivarsson, Ph.D., M.B.A., will join the company as its Chief Development Officer
January 30, 2020
· 3 min read